BCRX

BIOCRYST PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.10

EPS Forecast

$167

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$0.10

Revenue Forecast:

$167

EPS Surprise Forecast:

$0.036

Revenue Surprise Forecast:

$8

Post-release price volatility - High

Post-release Overnight Move:

±9.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

79%

Probability of beating revenue consensus:

76%

Probability of beating both EPS & revs consensus:

64%

Probability of missing both EPS & revs consensus:

9%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

1.20

Earnings volatility

EPS standard deviation:

$0.10

Revenue standard deviation:

$27

As % of share price:

1.04% VERY HIGH

As % of market cap:

1.09% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.23

Revenue 95th %ile:

$201

EPS 75th %ile:

$0.14

Revenue 75th %ile:

$176

EPS 25th %ile:

$0.07

Revenue 25th %ile:

$159

EPS 5th %ile:

-$0.01

Revenue 5th %ile:

$138

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

42% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

41% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$17

Bid-ask per Share:

$0.015